GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Wednesday, 26 Nov 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 04 or. 1 percent, to $72.40. Bristol-Myers Squibb Co. rose$. 34 or. 6 percent, to $58.86. Hospira rose$. 21 or. 3 percent, to $60.29.

  • Midday Glance: Pharmaceuticals companies Wednesday, 26 Nov 2014 | 2:02 PM ET

    Baxter International Inc. fell$. 02 or percent, to $72.42. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $58.55. Hospira rose$. 37 or. 6 percent, to $60.45.

  • Bristol-Myers: FDA blocks hepatitis C drug for now Wednesday, 26 Nov 2014 | 1:37 PM ET

    U.S. regulators have declined to approve Bristol-Myers Squibb's daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir. The FDA then requested more data on the effects of daclatasvir in combination with other drugs for treating hepatitis C, currently one of the hottest areas in drug research.

  • Bristol-Myers said it had initially sought permission from the U.S. Food and Drug Administration to market the drug, a so-called NS5A inhibitor, in combination with asunaprevir, one of the New York- based company's experimental medicines. But Bristol-Myers abandoned its U.S. marketing application for asunaprevir in October because of potential...

  • FDA declines to approve Bristol-Myers hepatitis drug Wednesday, 26 Nov 2014 | 11:56 AM ET

    Nov 26- Bristol-Myers Squibb Co on Wednesday said U.S. regulators had declined to approve use of its experimental daclatasvir drug for hepatitis C, in combination with other antiviral drugs.

  • Final Glance: Pharmaceuticals companies Tuesday, 25 Nov 2014 | 6:57 PM ET

    Bristol-Myers Squibb Co. fell$. 35 or. 6 percent, to $58.52. Hospira fell$. 22 or. 4 percent, to $60.08. Johnson& Johnson fell$. 18 or. 2 percent, to $106.70.

  • Midday Glance: Pharmaceuticals companies Tuesday, 25 Nov 2014 | 1:18 PM ET

    Baxter International Inc. rose$. 03 or percent, to $72.47. Bristol-Myers Squibb Co. fell$. 38 or. 6 percent, to $58.49. Pfizer rose$. 29 or 1.0 percent, to $30.51.

  • Early Glance: Pharmaceuticals companies Tuesday, 25 Nov 2014 | 10:22 AM ET

    Baxter International Inc. rose$. 01 or percent, to $72.45. Bristol-Myers Squibb Co. fell$. 75 or 1.3 percent, to $58.12. Hospira fell$. 34 or. 6 percent, to $59.96.

  • Final Glance: Pharmaceuticals companies Monday, 24 Nov 2014 | 6:08 PM ET

    Bristol-Myers Squibb Co. rose$. 07 or. 1 percent, to $58.87. Hospira rose $1.48 or 2.5 percent, to $60.30. Johnson& Johnson fell$. 98 or. 9 percent, to $106.88.

  • Lions Gate and Tesla are big market movers Monday, 24 Nov 2014 | 4:48 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Lions Gate Entertainment Corp., down 15 cents to $33.10. United Technologies Corp., down $1.51 to $108.79.

  • Five Prime in cancer drug deal with Bristol-Myers Monday, 24 Nov 2014 | 4:20 PM ET

    NEW YORK— Five Prime Therapeutics said Monday that it will study a cancer drug regimen that combines one of its drugs with a therapy developed by Bristol-Myers Squibb. It expects to start an early-stage clinical trial next year that combines Bristol-Myers Squibb Co.' s drug Opdivo with Five Prime's FPA008. Shares of Bristol-Myers Squibb Co. added 7 cents to...

  • Early Glance: Pharmaceuticals companies Monday, 24 Nov 2014 | 10:27 AM ET

    Baxter International Inc. fell$. 07 or. 1 percent, to $72.37. Hospira rose$. 13 or. 2 percent, to $58.95. Johnson& Johnson fell$. 17 or. 2 percent, to $107.69.

  • Final Glance: Pharmaceuticals companies Friday, 21 Nov 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $72.44. Bristol-Myers Squibb Co. rose$. 19 or. 3 percent, to $58.80. Hospira rose$. 29 or. 5 percent, to $58.82.

  • Early Glance: Pharmaceuticals companies Friday, 21 Nov 2014 | 10:18 AM ET

    Baxter International Inc. rose$. 74 or 1.0 percent, to $72.73. Bristol-Myers Squibb Co. rose$. 53 or. 9 percent, to $59.14. Hospira rose$. 58 or 1.0 percent, to $59.11.

  • Final Glance: Pharmaceuticals companies Thursday, 20 Nov 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 47 or. 6 percent, to $71.99. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $58.61. Hospira fell$. 28 or. 5 percent, to $58.53.

  • Midday Glance: Pharmaceuticals companies Thursday, 20 Nov 2014 | 2:49 PM ET

    Baxter International Inc. fell$. 72 or 1.0 percent, to $71.74. Bristol-Myers Squibb Co. fell$. 23 or. 4 percent, to $58.58. Hospira fell$. 33 or. 6 percent, to $58.48.

  • Early Glance: Pharmaceuticals companies Thursday, 20 Nov 2014 | 10:29 AM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $71.92. Bristol-Myers Squibb Co. fell$. 37 or. 6 percent, to $58.44. Hospira rose$. 11 or. 2 percent, to $58.92.

  • Final Glance: Pharmaceuticals companies Wednesday, 19 Nov 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $72.46. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $58.81. Hospira fell$. 91 or 1.5 percent, to $58.81.

  • Midday Glance: Pharmaceuticals companies Wednesday, 19 Nov 2014 | 1:31 PM ET

    Baxter International Inc. fell$. 12 or. 2 percent, to $72.46. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $58.57. Hospira fell $1.03 or 1.7 percent, to $58.69.

  • Early Glance: Pharmaceuticals companies Wednesday, 19 Nov 2014 | 12:01 PM ET

    Baxter International Inc. fell$. 02 or percent, to $72.56. Bristol-Myers Squibb Co. fell$. 23 or. 4 percent, to $58.47. Hospira fell$. 47 or. 8 percent, to $59.25.